Literature DB >> 940296

Control of mineralocorticoid substitution in Addison's disease by plasma renin measurement.

W Oelkers, M L'age.   

Abstract

In 7 out-patients with Addison's disease, plasma renin activity (PRA), plasma concentrations of angiotensin II (AT II), renin substrate (PRS), potassium, sodium and total protein, hematocrit, blood pressure, heart rate and body weight were studied after 2 weeks each on 2 mg of dexamethasone, 25 mg hydrocortisone (HC), 25 mg HC + 0.05 mg 9-alpha-fluorohydrocortisone (FC), 25 mg HC + 0.1 mg FC and 25 mg HC + 0.2 MG FC. Four further patients were less extensively studied. Mean PRA (upper normal limit, ambulatory: 12 ng AT I-ml-1-h-1) after the 5 steps of incremental substitution, starting with dexamethasone, was 192, 59, 38, 24 and 9 ng AT I-ml-1-h-1 rsp. PRS did not change with increasing substitution. PRA and AT II were significantly correlated (r = 0.91; p less than 0.0001) and proved to be the most sensitive parameters of insufficient mineralocorticoid substitution. With decreasing significance, PRA also correlated with plasma protein concentration, plasma sodium concentration (negative), delta body weight (negative), heart rate, delta mean blood pressure (negative) and plasma potassium concentration. PRA or AT II measurements are useful clinical tools to control mineralocorticoid substitution in Addisonian patients. Inappropriately high substitution can be prevented by keeping PRA in the upper normal range.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 940296     DOI: 10.1007/bf01469025

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  18 in total

1.  VARIATIONS IN PLASMA RENIN CONCENTRATION IN SEVERAL PHYSIOLOGICAL AND PATHOLOGICAL STATES.

Authors:  J J BROWN; D L DAVIES; A F LEVER; J I ROBERTSON
Journal:  Can Med Assoc J       Date:  1964-01-25       Impact factor: 8.262

2.  Role of gluco- and mineralocorticoids in salt and water metabolism of adrenalectomized dogs.

Authors:  W W SWINGLE; J P DAVANZO; D GLENISTER; H C CROSSFIELD; G WAGLE
Journal:  Am J Physiol       Date:  1959-02

3.  Mechanism of extracellular sodium and chloride depletion in the adrenalectomized dog.

Authors:  J B Flanagan; A K Davis; R R Overman
Journal:  Am J Physiol       Date:  1950-01

4.  Studies on angiotensinogen formation in a liver perfusion system.

Authors:  A Nasjletti; G M Masson
Journal:  Circ Res       Date:  1972-09       Impact factor: 17.367

5.  Measurement of human plasma renin substrate concentration by angiotensin I radioimmunoassay: a discussion of methodical problems.

Authors:  A Blümel; W Oelkers
Journal:  Z Klin Chem Klin Biochem       Date:  1974-10

6.  Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man.

Authors:  W Oelkers; M Schöneshöfer; A Blümel
Journal:  J Clin Endocrinol Metab       Date:  1974-11       Impact factor: 5.958

7.  Studies concerning the regulation and importance of plasma angiotensinogen concentration in the dog.

Authors:  I A Reid; W H Tu; K Otsuka; T A Assaykeen; W F Ganong
Journal:  Endocrinology       Date:  1973-07       Impact factor: 4.736

8.  Renin, angiotensin, corticosteroids, and electrolyte balance in Addison's disease.

Authors:  J J Brown; R Fraser; A F Lever; J I Robertson; V H James; J McCusker; V Wynn
Journal:  Q J Med       Date:  1968-01

9.  Radioimmunoassay of free aldosterone and of its 18-oxo-glucuronide in human urine.

Authors:  P Vecsei; B Penke; A Joumaah
Journal:  Experientia       Date:  1972-05-15

10.  Plasma renin activity and aldosterone excretion rate in normal subjects. II. Effect of oral contraceptive agents.

Authors:  M G Crane; J J Harris
Journal:  J Clin Endocrinol Metab       Date:  1969-04       Impact factor: 5.958

View more
  7 in total

1.  Mineralocorticoids in the management of primary adrenocortical insufficiency.

Authors:  M Jadoul; A Ferrant; J F De Plaen; J Crabbé
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

Review 2.  Adrenal insufficiency.

Authors:  Stefanie Hahner; Richard J Ross; Wiebke Arlt; Irina Bancos; Stephanie Burger-Stritt; David J Torpy; Eystein S Husebye; Marcus Quinkler
Journal:  Nat Rev Dis Primers       Date:  2021-03-11       Impact factor: 52.329

Review 3.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

Review 4.  Diabetic and endocrine emergencies.

Authors:  T Kearney; C Dang
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

5.  Use of plasma renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone.

Authors:  M E Baumstark; J Nussberger; F S Boretti; M W Baumstark; B Riond; C E Reusch; N S Sieber-Ruckstuhl
Journal:  J Vet Intern Med       Date:  2014 Sep-Oct       Impact factor: 3.333

Review 6.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958

7.  Desoxycorticosterone Pivalate Duration of Action and Individualized Dosing Intervals in Dogs with Primary Hypoadrenocorticism.

Authors:  J A Jaffey; P Nurre; A B Cannon; A E DeClue
Journal:  J Vet Intern Med       Date:  2017-09-11       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.